What is the first‑choice topical antibiotic for bacterial conjunctivitis (pink eye) in a healthy adult or child?

First-Choice Topical Antibiotic for Bacterial Conjunctivitis

For mild bacterial conjunctivitis in healthy adults and children, select any broad-spectrum topical antibiotic based on convenience and cost—there is no superior first-line agent, and you should choose the least expensive or most accessible option for a 5-7 day course. 1

Treatment Algorithm by Severity

Mild Bacterial Conjunctivitis (Most Common)

The 2024 American Academy of Ophthalmology guidelines explicitly state that no clinical evidence suggests superiority of any particular antibiotic for mild cases 1. This means:

• Choose based on cost and convenience, not drug class
• Common options include:
  • Polymyxin B-trimethoprim drops
  • Polymyxin B-bacitracin ointment
  • Erythromycin ointment
  • Fluoroquinolones (moxifloxacin, ciprofloxacin) if cost is not prohibitive

Duration: 5-7 days, four times daily 1

Important context: Mild bacterial conjunctivitis is self-limited and resolves spontaneously in immunocompetent patients. Antibiotics provide earlier clinical resolution (days 2-5) but this advantage diminishes by days 6-10 1. The primary benefits are reducing transmissibility and allowing earlier return to school/work 1.

Alternative When Antibiotics Are Limited

Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics and should be considered when antibiotic access is limited 1.

Moderate to Severe Bacterial Conjunctivitis

When you see copious purulent discharge, pain, and marked inflammation:

1. Obtain conjunctival cultures and Gram stain before starting treatment 1
2. Start empiric broad-spectrum coverage
3. Adjust based on culture results, particularly for:
   • MRSA (increasingly common, resistant to many topical antibiotics) 1
   • Gram-negative organisms in neonates (often gentamicin-resistant) 1
   • May require compounded vancomycin for MRSA 1

Special Situations Requiring Systemic Antibiotics

Gonococcal conjunctivitis: Requires systemic antibiotics (not topical alone) plus saline lavage. Consider sexual abuse in children. Daily follow-up mandatory 1.

Chlamydial conjunctivitis: Requires systemic antibiotics because >50% of infants have infection at other sites (nasopharynx, genital tract, lungs). No benefit to adding topical therapy 1.

Common Pitfalls to Avoid

1. Don't assume newer/expensive is better: Research from 1984 to 2024 consistently shows no superiority among antibiotic classes for uncomplicated cases 1, 2, 3

2. Don't over-treat viral conjunctivitis: Most conjunctivitis is viral, not bacterial. Antibiotics won't help and contribute to resistance 4, 5

3. Don't miss gonococcal/chlamydial cases: These require systemic treatment and have serious complications if treated with topical antibiotics alone 1

4. Follow-up timing: Advise patients to return in 3-4 days if no improvement 1

Evidence Quality Note

The 2024 AAO Conjunctivitis Preferred Practice Pattern 1 represents the highest quality, most recent guideline evidence. It explicitly states the lack of superiority among antibiotics, which is supported by a 2023 Cochrane review showing antibiotics increase clinical cure by 26% versus placebo (RR 1.26), with no subgroup differences by antibiotic class 3. Historical research supports polymyxin-bacitracin as effective 2, while more recent studies show fluoroquinolones and other agents work equally well 6, 7, 8.

The key clinical decision is whether to treat at all, not which antibiotic to choose.